Patents by Inventor Donald J. Fauss

Donald J. Fauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
    Patent number: 5674888
    Abstract: The invention concerns the recognition that certain non-steroidal anti-inflammatory agents can overcome or ameliorate limitations on trabecular meshwork cell division produced by environmental stresses (e.g., oxidative or phagocytic injury, or glucocorticoid exposure), and thus can be used to prevent or treat loss of trabecular cells found in certain forms of glaucoma and in normal aging. The use of such non-steroidal anti-inflammatory agents can ameliorate the severity, or prevent glaucoma.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 1997
    Assignee: University of California
    Inventors: Jon R. Polansky, Ernest Bloom, Donald J. Fauss
  • Methods for the cyto-protection of the trabecular meshwork
    Patent number: 5599535
    Abstract: The invention concerns the recognition that certain non-steroidal anti-inflammatory agents produce cytoprotective effects on trabecular cells, and thus can be used to prevent injury to the cells and treat the loss of trabecular cells caused by oxidative or other forms of injury to the cells. Such treatment can ameliorate the severity, or prevent, glaucoma.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 4, 1997
    Assignee: Regents of the University of California
    Inventors: Jon R. Polansky, Ernest Bloom, Donald J. Fauss
  • Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
    Patent number: 5474985
    Abstract: Methods and compositions for preventing or treating non-inflammatory elevated intraocular pressure associated with administered or endogenous steroids including administering to a mammalian organism a composition including (a) an ophthalmologically effective amount of a non-steroidal cyclooxygenase inhibitor, and (b) a pharmaceutically acceptable carrier, to reduce or prevent an elevation of intraocular pressure and/or protein marker induction induced by chronic exposure to glucocorticoids.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: December 12, 1995
    Assignee: The Regents of the University of California
    Inventors: Jon R. Polansky, Ernest Bloom, Donald J. Fauss